Belharra Therapeutics, disrupts the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform, $50M Series A with Versant Ventures
ADARx Pharmaceuticals, genetic medicine company focusing on the base editing of mRNA transcripts, $46M Series B with Ascenta Capital
Alume Biosciences, developing nerve-targeted pharmaceuticals for surgical and therapeutic use, $13M Series B
Splitero, provide homeowners with better options to access home equity without new debt or additional monthly payments, $11.7M Series A with Fiat Ventures
Personal AI, develops AI-based software to help users retain, reinforce, and recall human memory, $7.8M Seed with Supernode Global
Anokiwave, silicon core chip solutions that reduce system cost and enable rapid technology adoption, $4.8M
PiKNiK & Company, develops mining servers and enterprise storages to act as data storage partner for Web 3.0., $3M
CARI Health, develops remote medication monitors that allow clinicians to precision dose and increase adherence to lifesaving therapeutics, $2.3M Seed with San Diego Angel Conference
CRISPR QC, CRISPR QC Analytics Platform gives the information and understanding they require to fuel the safest, most effective gene editing results, $1.6M Seed with Serra Ventures
The BXNG Club, fitness center offering classes, training, and workout programs for high-intensity interval training-based fitness, $350k Seed
CB Therapeutics, specializes in the biosynthetic production of cannabinoids from sugar, Series A with Mystic Ventures
